Efficacy of Rifaximin in Patients With Abdominal Bloating or Distension: A Systematic Review and Meta-analysis.

Umang AroraKaran SachdevaPrerna GargUpendra BaithaSaurabh KediaMani KalaivaniVineet AhujaArvind KumarPiyush RanjanNaval K VikramSanjeev SinhaAshutosh BiswasNaveet Wig

Published in: Journal of clinical gastroenterology (2023)

Rifaximin therapy is associated with an increased likelihood of improvement in bloating and distension, as well as reduces the subjective severity of these symptoms in patients with FGID.

Keyphrases

irritable bowel syndrome
sleep quality
stem cells
bone marrow
smoking cessation